Lei, Du
Li, Wenbin
Qin, Kun
Ai, Yuan
Tallman, Maxwell J. http://orcid.org/0000-0003-3036-561X
Patino, L. Rodrigo
Welge, Jeffrey A.
Blom, Thomas J.
Klein, Christina C.
Fleck, David E.
Gong, Qiyong http://orcid.org/0000-0002-5912-4871
Adler, Caleb M.
Strawn, Jeffrey R.
Sweeney, John A. http://orcid.org/0000-0003-1752-2828
DelBello, Melissa P.
Funding for this research was provided by:
National Natural Science Foundation of China (NSFC81820108018)
U.S. Department of Health & Human Services | NIH | National Institute of Mental Health (5R01MH080973)
Article History
Received: 4 May 2022
Revised: 11 September 2022
Accepted: 14 September 2022
First Online: 13 October 2022
Competing interests
: JRS has received research support from the National Institutes of Health (NIMH/NIEHS/NICHD) as well as Allergan, Neuronetics and Otsuka. He has received material support from and provided consultation to Myriad Genetics and receives royalties from the publication of two texts (Springer) and serves as an author for UpToDate and an Associate Editor for Current Psychiatry. He has spoken in CME presentations for Neuroscience Education Institute and CMEology. JRS also has provided consultation to the FDA and Intracellular Therapeutics. JAS consults to VeriSci. LRP and MPD have received research support from NIMH, PCORI, Acadia, Alkermes, Allergan, Janssen, Johnson and Johnson, Lundbeck, Myriad, Otsuka, Pfizer, Sunovion and Shire. MPD has provided consultation or advisory board services for Alkermes, Allergan, CMEology, Janssen, Johnson and Johnson, Lundbeck, Medscape, Myriad, Pfizer, Sage, and Sunovion. All other authors declare that they have no competing interests.